Aesthetics

Module VI (USA): Intensive Hands-on Procedural Training In Chemical Peels, Sclerotherapy, and Body Contouring

2018 - 04 - Aesthetic Fellowship Hands On

Module VI - April 21-22

Only: $2,500.00
ADD TO CART

2018 - 07 - Aesthetic Fellowship Hands On

Module VI - July 28-29

Only: $2,500.00
ADD TO CART

DAY ONE: The Use of Botulinum Toxin for Aesthetic Enhancement

Upon completion of the module, the participant will:

  • Understand the incidence, prevalence, etiology, pathology, and clinical presentation of venous disease
  • Demonstrate of working knowledge of venous anatomy including: the Anterior Tibial, Posterior Tibial, Peroneal, Popliteal. Femoral, Common Femoral, Perforators, Greater Saphenous, Short Saphenous, reticular and spider veins
  • Conduct an aesthetic consultation with patients desiring treatment of venous disease including patient education regarding the progressive and chronic nature of venous disease, to establish reasonable patient expectations for treatment
  • Demonstrate the ability to perform a medical history and physical examination to accurately predict the extent of venous disease
  • Utilize diagnostic tools including cw doppler, transillumination, photoplethysmography, and duplex ultrasonography for diagnosing the extent of venous disease in individual patients
  • Have a working knowledge of the properties of the available sclerosants including the standard concentrations used for each size of vessel. The sclerosants used include hypertonic saline, sotradecol, and polidocanol. Sources, pricing, and practical experience with dilution will be made available for all of these products
  • Develop and understanding of the advantages and disadvantages of insurance billing for the treatment of venous disease. Forms, methodology, and cpt codes discussed
  • Prescribe the appropriate type of compression stocking for each venous treatment and understand it's important role in achieving successful clinical outcomes
  • Understand the indications and contraindications of each form of sclerotherapy as well as the risks and potential complications. Understand the increase risk of sclerotherapy in patients on HRT or who have hypercoagulability states and how to manage these risks
  • Have a working knowledge of how to diagnose and treat the complications of sclerotherapy including deep venous thrombosis, superficial phlebitis, necrosis, intra-arterial injection, tissue necrosis, hemosiderin staining, and hyperpigmentation
  • Participate in an interactive demonstration sessions with vascular experts delivering "best practice" standards in sclerotherapy
  • Develop skill in performing sclerotherapy on live patients with specialists according to "best practice" standards including consultation, physical exam, diagnostic studies, diagnosis, patient education, and appropriate post procedural care
  • Submit a case study to receive Level 4 CME through USF Department of Professional Development

DAY TWO: Sclerotherapy in Aesthetic Medicine

Upon completion of the module, the participant will:

  • Understand the incidence, prevalence, etiology, pathology, and clinical presentation of venous disease
  • Demonstrate of working knowledge of venous anatomy including: the Anterior Tibial, Posterior Tibial, Peroneal, Popliteal. Femoral, Common Femoral, Perforators, Greater Saphenous, Short Saphenous, reticular and spider veins
  • Conduct an aesthetic consultation with patients desiring treatment of venous disease including patient education regarding the progressive and chronic nature of venous disease, to establish reasonable patient expectations for treatment
  • Demonstrate the ability to perform a medical history and physical examination to accurately predict the extent of venous disease
  • Utilize diagnostic tools including cw doppler, transillumination, photoplethysmography, and duplex ultrasonography for diagnosing the extent of venous disease in individual patients
  • Have a working knowledge of the properties of the available sclerosants including the standard concentrations used for each size of vessel. The sclerosants used include hypertonic saline, sotradecol, and polidocanol. Sources, pricing, and practical experience with dilution will be made available for all of these products
  • Develop and understanding of the advantages and disadvantages of insurance billing for the treatment of venous disease. Forms, methodology, and cpt codes discussed
  • Prescribe the appropriate type of compression stocking for each venous treatment and understand it's important role in achieving successful clinical outcomes
  • Understand the indications and contraindications of each form of sclerotherapy as well as the risks and potential complications. Understand the increase risk of sclerotherapy in patients on HRT or who have hypercoagulability states and how to manage these risks
  • Have a working knowledge of how to diagnose and treat the complications of sclerotherapy including deep venous thrombosis, superficial phlebitis, necrosis, intra-arterial injection, tissue necrosis, hemosiderin staining, and hyperpigmentation
  • Participate in an interactive demonstration sessions with vascular experts delivering "best practice" standards in sclerotherapy
  • Develop skill in performing sclerotherapy on live patients with specialists according to "best practice" standards including consultation, physical exam, diagnostic studies, diagnosis, patient education, and appropriate post procedural care
  • Submit a case study to receive Level 4 CME through USF Department of Professional Development

Along with the expert knowledge gained in Module III, this module will enable attendees to deliver expert care to patients with venous disease.